{"id":"W4206298574","doi":"10.1016/j.jval.2021.11.153","title":"POSC7 Work Productivity and Activity Impairment for Patients with Moderate to Severe Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Phase 3 Trials (CIMPASI-1 AND CIMPASI-2)","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Certolizumab pegol; Medicine; Presenteeism; Absenteeism; Placebo; Psoriatic arthritis; Work productivity; Physical therapy; Internal medicine; Productivity; Arthritis; Disease; Adalimumab; Psychology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002620305,0.001365245,0.00216664,0.0004124522,0.0005238341,0.001258938,0.0008036477,0.001801105,0.001975359],"category_scores_gemma":[0.001803408,0.0003689716,0.003571137,0.0006169298,0.0007548019,0.0007765083,0.0004751346,0.002718836,0.0004520085],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007967379,"about_ca_system_score_gemma":0.001404047,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003059691,"about_ca_topic_score_gemma":0.00349465,"domain_scores_codex":[0.9990386,0.0004905827,0.00005227371,0.0001312152,0.0001284653,0.0001588326],"domain_scores_gemma":[0.9981261,0.0004821568,0.000445041,0.0001284355,0.0001472314,0.0006710965],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8638634,0.006808195,0.04332479,0.0004894237,0.004213958,0.0001566255,0.00012104,0.001112263,0.004135003,0.00009745818,0.002041271,0.07363652],"study_design_scores_gemma":[0.4092051,0.2559642,0.323316,0.0001332656,0.004640515,0.0003672744,0.0002286069,0.00201214,0.001521098,0.0003022702,0.002206561,0.0001029379],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.990411,0.006248397,0.0002266805,0.0006256754,0.0001276664,0.0002678499,0.001132117,0.00004672769,0.000913833],"genre_scores_gemma":[0.9945844,0.001839102,0.0003017029,0.000490978,0.0001674148,0.0002197122,0.001763163,0.000009959732,0.0006234752],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003059691,"threshold_uncertainty_score":0.01385766,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04380790334745937,"score_gpt":0.289780443493676,"score_spread":0.2459725401462166,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}